Physician profile
Sanjay Goyal
NPI 1164400156
$11,677.78
in general payments reported to CMS, 2019-2025
33 companies · $1,874 in 2025
The $1,874 reported for 2025 was more than what 75% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $1,492 · 2021: $1,265 · 2022: $1,346 · 2023: $1,542 · 2024: $1,871 · 2025: $1,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,287.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $1,944.62 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,496.01 | 2019-2025 | Jardiance, Tradjenta |
| Novo Nordisk INC | $1,255.74 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,018.30 | 2019-2025 | Jardiance, Jaypirca, Mounjaro |
| Cequr Corporation | $636.35 | 2023-2025 | Cequr Simplicity |
| Abbott Laboratories | $512.38 | 2021-2024 | Freestyle Libre 3 |
| Medtronic, INC. | $506.40 | 2021-2025 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Mallinckrodt Hospital Products INC. | $485.74 | 2020-2023 | Acthar |
| Astrazeneca Pharmaceuticals Lp | $381.34 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $347.00 | 2019 | |
| Boston Scientific Corporation | $341.57 | 2020-2025 | Avvigo Guidance System |
| Amgen INC. | $269.75 | 2024-2025 | Tepezza |
| Xeris Pharmaceuticals, INC. | $253.10 | 2024-2025 | Gvoke Hypopen |
| Mylan Specialty L.P. | $244.94 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $243.83 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $237.30 | 2019-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Merck Sharp & Dohme LLC | $234.11 | 2019-2021 | |
| Abbvie INC. | $165.41 | 2019-2025 | |
| Horizon Therapeutics Plc | $161.60 | 2023 | Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Alkermes, INC. | $124.99 | 2019 | |
| Exelixis INC. | $124.97 | 2024 | Cabometyx |
| Sunovion Pharmaceuticals INC. | $124.97 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $124.96 | 2022 | |
| Corcept Therapeutics | $97.20 | 2023-2025 | Korlym |
| Amneal Pharmaceuticals LLC | $59.45 | 2023-2024 | Unithroid |
| Ascendis Pharma Endocrinology INC | $40.70 | 2025 | Yorvipath |
| Medtronic Minimed, INC. | $27.59 | 2020 | |
| Amarin Pharma, INC. | $22.60 | 2019 | |
| Valeritas, INC. | $21.18 | 2019 | |
| Mannkind Corporation | $18.05 | 2019 | |
| Madrigal Pharmaceuticals | $16.73 | 2025 | Rezdiffra |
| Ascensia Diabetes Care US INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.